Camp4 Therapeutics CAMP
NASDAQ CAMP
$4.41 -0.08 (-1.79%)
As of: Sep 4, 2026 · 3:59 PM EDT

Camp4 Therapeutics (CAMP) Shares Outstanding (Entity) (2023 - 2026)

Analysis

Camp4 Therapeutics (CAMP) Shares Outstanding (Entity) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 399.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 214.24 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 113.02 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 133.73 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 575.00 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 218.28 Mn
10 Camp4 Therapeutics 260.10 Mn 260.10 Mn - 51.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.93 Mn
Mar 31, 2026 51.93 Mn
Dec 31, 2025 30.38 Mn
Sep 30, 2025 27.27 Mn
Jun 30, 2025 20.16 Mn
Mar 31, 2025 20.16 Mn
Dec 31, 2024 4.69 Mn
Sep 30, 2024 557,437.00
Jun 30, 2024 490,877.00
Mar 31, 2024 476,266.00
Dec 31, 2023 460,704.00
Sep 30, 2023 400,426.00